drugset / Trial / NCT00802451

Bioavailability Study of Two Mesalamine 4 gm/60 ml Rectal Enema Formulations

NCT00802451

Completed 48 enrolled Padagis LLC
RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study is to evaluate the relative bioavailability of the test formulation of mesalamine suspension rectal enema with the reference formulation in healthy, adult subjects.

Timeline

Start
2003-02
Primary completion
2003-03
Completion
2003-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Mesalamine Small molecule 4 g Rectal

Indications

No indication recorded.